Legislation recently enacted at the state level requires local schools to allow students to be released during the school day ...

Seeking mental health help is a significant step, but that first intake session can often feel more like paperwork than ...

We are also excited to have a strong group of investors join NeuroPace as part of our recent financing,” said Joel Becker, Chief Executive Officer of NeuroPace. “We would also like to thank KCK Ltd.

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval- ...

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...

Q4 2024 Earnings Call Transcript February 18, 2025 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS is $0.397, expectations were $0.31. Operator: Please standby. Welcome, ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Total 4Q and full year 2024 net product revenue of $118.8 million and $385.7 million, respectively, representing 66% and 88% year-over-year ...

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

Presidents' Day weekend is here, and there are countless deals to look at. And, honest to Abe Lincoln, we're scanning every ...